Get started
Author

Loukas Kontovinis

Observed names: L F Kontovinis, L Kontovinis, L. Kontovinis, LOUKAS KONTOVINIS, Loukas F Kontovinis, Lukas F Kontovinis, Λουκάς Κοντοβίνης
ORCID: 0000-0002-8863-7465
Observed ORCID: 0000-0002-8863-7465
OpenAlex ID: A5077280857
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
2009 · Loukas F Kontovinis, Konstantinos T Papazisis, et al. · BMC Cancer · 89
PDF
Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation
2017 · Aristotle Bamias, Bernard Escudier, et al. · The Oncologist · 86
PDF
Prognostic Significance of Low HER2 Expression in Patients With Early Hormone Receptor Positive Breast Cancer
2022 · GEORGE DOUGANIOTIS, LOUKAS KONTOVINIS, et al. · Cancer Diagnosis & Prognosis · 38
Erythropoiesis stimulating agents are associated with reduced survival in patients with multiple myeloma
2008 · Eirini Katodritou, Evgenia Verrou, et al. · American Journal of Hematology · 31
Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model
2010 · Aristotelis Bamias, Alexandra Karadimou, et al. · BMC Cancer · 29
PDF
Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma
2010 · Konstantinos T Papazisis, Lukas F Kontovinis, et al. · BMC Cancer · 21
PDF
Biological markers in breast cancer prognosis and treatment.
2010 · G Kesisis, L F Kontovinis, et al. · PubMed · 18
Sequential treatment with sorafenib and sunitinib in metastatic renal cell carcinoma: clinical outcomes from a retrospective clinical study
2011 · Loukas Kontovinis, Konstantinos Laschos, et al. · Medical Oncology · 14
The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking
2023 · Aikaterini Tsantikidi, Eirini Papadopoulou, et al. · Diagnostics · 8
PDF
Ribociclib and palbociclib-induced erythema multiforme: a case report
2022 · Eleni Vrana, Stella Mylona, et al. · Oxford Medical Case Reports · 7
PDF
Association of Oncotype-DX HER2 Single Gene Score With HER2 Expression Assessed by Immunohistochemistry in HER2-low Breast Cancer
2024 · GEORGE DOUGANIOTIS, LOUKAS KONTOVINIS, et al. · Cancer Diagnosis & Prognosis · 4
PDF
Assessment of parameters associated with ovarian function recovery in premenopausal women with early breast cancer and chemotherapy-induced amenorrhea in real-world clinical practice
2025 · George Douganiotis, Efrosini Markopoulou, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 3
Real-world experience of neoadjuvant chemotherapy for early breast cancer patients: an observational non-interventional study in Thessaloniki, Greece.
2020 · Konstantinos T Papazisis, Triantafyllos Liappis, et al. · PubMed · 3
The Role of the NOLUS Score in Predicting pCR and iDFS in HR-positive HER2-negative Early Breast Cancer Patients who Received Neoadjuvant Chemotherapy
2024 · ANNA-LEA AMYLIDI, LOUKAS KONTOVINIS, et al. · Cancer Diagnosis & Prognosis · 2
PDF
1707P CureCancer digital tool in the routine clinical oncology practice facilitates PROs, communicating with HCPs, treatment adherence and “distancing interventions” during COVID-19 and reduces costs: A feasibility and satisfaction study
2020 · D. Galiti, S. Agelaki, et al. · Annals of Oncology · 2
PDF
Everolimus as second-line treatment in metastatic renal cell carcinoma (mRCC) after first-line pazopanib (The RESCUE study): A retrospective analysis by the Hellenic GU Cancer Group (HGUCG) with international collaboration.
2015 · Konstantinos Koutsoukos, Marta Espinosa Montano, et al. · Journal of Clinical Oncology · 2
Changes in cancer tissue induced by treatment with bevacizumab in metastatic breast cancer.
2010 · G. Kesisis, P. Touplikioti, et al. · Journal of Clinical Oncology · 2
Targeted treatment for metastatic renal cell carcinoma and immune regulation.
2010 · K A Laschos, K T Papazisis, et al. · PubMed · 2
Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece—The TRINITY Study
2025 · Konstantinos Papazisis, Christos Christodoulou, et al. · Cancers · 1
PDF
Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece
2016 · A Solakidi, G Kourlaba, et al. · Value in Health · 1
Abstract P1-05-09: High prevalence of germline BRCA1/2 pathogenic variants in TNBC patients who achieve pCR: results from the TRINITY study
2025 · Emmanouil Saloustros, Christos Christodoulou, et al. · Clinical Cancer Research
63P Predicting oncotype-dx outcomes in resource-limited settings: The role of NOLUS immunohistochemical score
2025 · A.L. Amylidi, G. Douganiotis, et al. · ESMO Open
Distribution and Prevalence of Germline Mutations in Patients with Early Breast Cancer and Their Correlation with Disease-Free Survival: Real-World Clinical Practice Data in North Greece
2024 · Eleni Vrana, George Douganiotis, et al. · Research Square
The application of a multigene NGS assay in homologous recombination deficiency tracking.
2023 · Nikolaos Tsoulos, Aikaterini Tsantikidi, et al. · Journal of Clinical Oncology
PDF
Cardiac safety of neoadjuvant chemotherapy with epirubicin and cyclophosphamide followed by docetaxel/pertuzumab/trastuzumab for HER2-positive breast cancer patients.
2021 · George Douganiotis, Savvas Grigoriadis, et al. · PubMed
Works count: 30
Citation count: 363
H-index: 8
I10-index: 8
Year
Topic
Type